ATR vs. GSK: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ATR and GSK, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
ATR is a standard domestic listing, while GSK trades as an American Depositary Receipt (ADR), offering U.S. investors access to its foreign-listed shares.
| Symbol | ATR | GSK |
|---|---|---|
| Company Name | AptarGroup, Inc. | GSK plc |
| Country | United States | United Kingdom |
| GICS Sector | Materials | Health Care |
| GICS Industry | Containers & Packaging | Pharmaceuticals |
| Market Capitalization | 9.30 billion USD | 80.75 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | April 23, 1993 | March 28, 1980 |
| Security Type | Common Stock | ADR |
Historical Performance
This chart compares the performance of ATR and GSK by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ATR | GSK |
|---|---|---|
| 5-Day Price Return | -1.30% | 1.15% |
| 13-Week Price Return | -11.09% | 2.54% |
| 26-Week Price Return | -1.49% | 0.48% |
| 52-Week Price Return | -4.86% | -9.05% |
| Month-to-Date Return | -11.17% | 2.36% |
| Year-to-Date Return | -11.15% | 7.80% |
| 10-Day Avg. Volume | 0.54M | 4.40M |
| 3-Month Avg. Volume | 0.39M | 7.12M |
| 3-Month Volatility | 26.60% | 24.50% |
| Beta | 0.58 | 0.93 |
Profitability
Return on Equity (TTM)
ATR
15.28%
Containers & Packaging Industry
- Max
- 41.66%
- Q3
- 20.76%
- Median
- 14.35%
- Q1
- 6.55%
- Min
- 3.64%
ATR’s Return on Equity of 15.28% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.
GSK
24.18%
Pharmaceuticals Industry
- Max
- 38.59%
- Q3
- 19.84%
- Median
- 11.90%
- Q1
- 5.63%
- Min
- -9.96%
In the upper quartile for the Pharmaceuticals industry, GSK’s Return on Equity of 24.18% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
ATR
10.84%
Containers & Packaging Industry
- Max
- 11.61%
- Q3
- 8.17%
- Median
- 4.91%
- Q1
- 4.20%
- Min
- 0.08%
A Net Profit Margin of 10.84% places ATR in the upper quartile for the Containers & Packaging industry, signifying strong profitability and more effective cost management than most of its peers.
GSK
10.82%
Pharmaceuticals Industry
- Max
- 34.51%
- Q3
- 17.73%
- Median
- 12.12%
- Q1
- 5.99%
- Min
- -7.73%
GSK’s Net Profit Margin of 10.82% is aligned with the median group of its peers in the Pharmaceuticals industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ATR
14.30%
Containers & Packaging Industry
- Max
- 22.03%
- Q3
- 13.17%
- Median
- 8.87%
- Q1
- 6.86%
- Min
- 0.07%
An Operating Profit Margin of 14.30% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
GSK
16.22%
Pharmaceuticals Industry
- Max
- 41.53%
- Q3
- 23.00%
- Median
- 16.24%
- Q1
- 9.24%
- Min
- -6.94%
GSK’s Operating Profit Margin of 16.22% is around the midpoint for the Pharmaceuticals industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | ATR | GSK |
|---|---|---|
| Return on Equity (TTM) | 15.28% | 24.18% |
| Return on Assets (TTM) | 8.49% | 5.77% |
| Net Profit Margin (TTM) | 10.84% | 10.82% |
| Operating Profit Margin (TTM) | 14.30% | 16.22% |
| Gross Profit Margin (TTM) | 38.32% | 71.77% |
Financial Strength
Current Ratio (MRQ)
ATR
1.21
Containers & Packaging Industry
- Max
- 2.13
- Q3
- 1.57
- Median
- 1.27
- Q1
- 1.13
- Min
- 0.58
ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.
GSK
0.87
Pharmaceuticals Industry
- Max
- 4.49
- Q3
- 2.77
- Median
- 1.74
- Q1
- 1.26
- Min
- 0.11
GSK’s Current Ratio of 0.87 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
ATR
0.40
Containers & Packaging Industry
- Max
- 4.50
- Q3
- 2.23
- Median
- 1.22
- Q1
- 0.54
- Min
- 0.23
Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
GSK
1.17
Pharmaceuticals Industry
- Max
- 2.44
- Q3
- 1.07
- Median
- 0.42
- Q1
- 0.11
- Min
- 0.00
GSK’s leverage is in the upper quartile of the Pharmaceuticals industry, with a Debt-to-Equity Ratio of 1.17. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
Interest Coverage Ratio (TTM)
ATR
16.66
Containers & Packaging Industry
- Max
- 13.16
- Q3
- 8.10
- Median
- 3.61
- Q1
- 2.94
- Min
- 1.06
With an Interest Coverage Ratio of 16.66, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.
GSK
2.37
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 44.18
- Median
- 9.83
- Q1
- 2.82
- Min
- -42.71
In the lower quartile for the Pharmaceuticals industry, GSK’s Interest Coverage Ratio of 2.37 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.
Financial Strength at a Glance
| Symbol | ATR | GSK |
|---|---|---|
| Current Ratio (MRQ) | 1.21 | 0.87 |
| Quick Ratio (MRQ) | 0.83 | 0.57 |
| Debt-to-Equity Ratio (MRQ) | 0.40 | 1.17 |
| Interest Coverage Ratio (TTM) | 16.66 | 2.37 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ATR
1.30%
Containers & Packaging Industry
- Max
- 7.37%
- Q3
- 4.07%
- Median
- 3.33%
- Q1
- 1.72%
- Min
- 0.00%
ATR’s Dividend Yield of 1.30% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.
GSK
4.26%
Pharmaceuticals Industry
- Max
- 6.98%
- Q3
- 3.32%
- Median
- 2.13%
- Q1
- 0.14%
- Min
- 0.00%
With a Dividend Yield of 4.26%, GSK offers a more attractive income stream than most of its peers in the Pharmaceuticals industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
ATR
30.51%
Containers & Packaging Industry
- Max
- 221.20%
- Q3
- 119.52%
- Median
- 58.05%
- Q1
- 28.91%
- Min
- 0.00%
ATR’s Dividend Payout Ratio of 30.51% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
GSK
54.01%
Pharmaceuticals Industry
- Max
- 165.20%
- Q3
- 90.59%
- Median
- 49.13%
- Q1
- 28.91%
- Min
- 0.00%
GSK’s Dividend Payout Ratio of 54.01% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | ATR | GSK |
|---|---|---|
| Dividend Yield (TTM) | 1.30% | 4.26% |
| Dividend Payout Ratio (TTM) | 30.51% | 54.01% |
Valuation
Price-to-Earnings Ratio (TTM)
ATR
23.49
Containers & Packaging Industry
- Max
- 35.98
- Q3
- 27.87
- Median
- 16.15
- Q1
- 14.38
- Min
- 8.20
ATR’s P/E Ratio of 23.49 is within the middle range for the Containers & Packaging industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
GSK
17.09
Pharmaceuticals Industry
- Max
- 42.51
- Q3
- 26.88
- Median
- 19.11
- Q1
- 15.12
- Min
- 0.00
GSK’s P/E Ratio of 17.09 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ATR
2.55
Containers & Packaging Industry
- Max
- 2.91
- Q3
- 1.67
- Median
- 0.83
- Q1
- 0.64
- Min
- 0.30
ATR’s P/S Ratio of 2.55 is in the upper echelon for the Containers & Packaging industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
GSK
1.85
Pharmaceuticals Industry
- Max
- 7.55
- Q3
- 4.54
- Median
- 2.11
- Q1
- 1.52
- Min
- 0.00
GSK’s P/S Ratio of 1.85 aligns with the market consensus for the Pharmaceuticals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ATR
3.83
Containers & Packaging Industry
- Max
- 5.28
- Q3
- 3.30
- Median
- 2.35
- Q1
- 1.57
- Min
- 0.89
ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
GSK
3.84
Pharmaceuticals Industry
- Max
- 9.78
- Q3
- 4.96
- Median
- 2.23
- Q1
- 1.46
- Min
- 0.60
GSK’s P/B Ratio of 3.84 is within the conventional range for the Pharmaceuticals industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | ATR | GSK |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 23.49 | 17.09 |
| Price-to-Sales Ratio (TTM) | 2.55 | 1.85 |
| Price-to-Book Ratio (MRQ) | 3.83 | 3.84 |
| Price-to-Free Cash Flow Ratio (TTM) | 26.92 | 12.54 |